Patients with bisphosphonates‐associated osteonecrosis of the jaw have reduced circulating endothelial cells

Alessandro Allegra, Giacomo Oteri, Andrea Alonci, +7

Hematological Oncology

Influence of complex variant chromosomal translocations in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors

Fabio Stagno, Paolo Vigneri, Vittorio Del Fabro, +8

Acta Oncologica

Differential levels of soluble angiopoietin‐2 and Tie‐2 in patients with haematological malignancies

Eugenia Quartarone, Andrea Alonci, Alessandro Allegra, +6

European Journal Of Haematology

ImmunologyPathologySoluble Angiopoietin‐2Tumor AngiogenesisTumor Biology +15

Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network

Concetta Conticello, Alessandra Romano, Vittorio Del Fabro, +25

Journal of Clinical Medicine

Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy Via STAT3

Fabrizio Puglisi, Nunziatina Laura Parrinello, Cesarina Giallongo, +15

International Journal of Molecular Sciences

ImmunologyImmune RegulationPathologyInnate ImmunityImmune System +21

Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno‐microenvironment in multiple myeloma

Alessandro Barbato, Cesarina Giallongo, Sebastiano Giallongo, +14

Cell Proliferation

Chemoprevention StrategyImmunologyLactate ConcentrationImmunotherapyCancer Biology +14

Efficacy and safety of tixagevimab‐cilgavimab versus SARS‐CoV‐2 breakthrough infection in the hematological conditions

Andrea Duminuco, Antonella Nardo, Alessandra Orofino, +13

Cancer

Clinical Benefit of Long-Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients

Marina Parisi, Salvatore Leotta, Alessandra Romano, +10

Journal of Clinical Medicine

Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab

Andrea Duminuco, Alessandra Romano, Dario Leotta, +9

Frontiers in Oncology

Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies

Marzia Varettoni, Angela Ferrari, Anna Maria Frustaci, +21

American Journal of Hematology